Global Study On Transdermal Skin Patches Market Shares, Strategies And Forecasts Worldwide 2017 - 2025 - Credence Research

According to the latest report published by Credence Research, Inc. “Transdermal Skin Patches Market – (Product Type – Drug in Adhesive, Matrix, Reservoir, Vapor); (Application – Pain Relief, Nicotine Cessation, Hormone Replacement Therapy, Motion Sickness, Neurological Disorders, Cardiovascular Disorders and Others): Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the market is expected to expand at a CAGR of 4.2% from 2017 to 2025.
Market Insights
Transdermal drug delivery has been an attractive and challenging area of research.  Advances in modern technologies are resulting in a larger number of drugs being delivered transdermally including conventional hydrophobic small molecule drugs, hydrophilic drugs and macromolecules. Transdermal delivery provides convenient and pain-free self-administration of drugs as leading to patient compliance especially in the chronic condition where long term treatment is necessary.
Browse the full report Transdermal Skin Patches Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 report at http://www.credenceresearch.com/report/transdermal-skin-patches-market
Patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication. Based on the type of product type, the transdermal skin patches market is categorized into matrix, drug in adhesive, reservoir and vapor. The matrix segment held the largest share in the overall transdermal skin patches market due to product modification in terms of controlled release setting. Moreover, non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drug with controlled precision would further drive the market in the future. On the basis of application the transdermal skin patches are segmented into pain relief, nicotine cessation, hormone replacement therapy, motion sickness, neurological disorders, cardiovascular disorders, and others. Transdermal patches for pain relief is the major contributing market as they are preferred over hypodermic injections, which are more painful, generate medical waste, and pose a risk of disease transmission. Improved patient compliance as the treatment is non-invasive, simple, and convenient, and there is greater flexibility in termination of drugs by the removal of patches.
Geographically, North America dominated the global medical foods market which was followed by Europe.  The key market drivers assisting in the growth of North America transdermal skin patches comprises rise in research and development in non-invasive methods of treatment for chronic conditions such as pain relief, motion sickness and other lifestyle related disorders. Moreover, the developed countries like U.S. U.K and others in North America and Europe, the adoption rate of the non-invasive and novel treatment is more than the developing nations. However, Asia Pacific has emerged as the fastest growing region in the transdermal skin patches market due to rising demand for better treatment at affordable cost in the region. Furthermore, innovation and government funding in the development of cutting-edge technology and healthcare infrastructure would augment the growth of Asia Pacific transdermal skin patches market.
Market Competition Assessment:
The transdermal skin patches market currently have comprises number of companies marketing their products in the market. The major companies in the he major players in the transdermal skin patches market include Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals Inc, 3M Company, Accrux Ltd., Access Pharmaceuticals Inc., and others.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist works straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Post a Comment

Popular posts from this blog

Global Emu Oil Market Analysis and Forecast 2017- 2025 - Credence Research

According to a new market report published by Credence Research “ Emu Oil Market  Growth, Future Prospects and Competitive Analysis, 2016 – 2024,” the global emu oil market is expected to reach over US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Market Insights The global emu oil market is progressing at a considerable pace and is anticipated to attain significant market size over the next few years. Emu oil is manufactured using natural product from emu bird, and is widely used in various applications such as skin care, face care, hair care, medical and others. The global emu oil market was valued at US$ 94.34 Mn in 2015, and is expected to reach US$ 154.05 Mn by 2024, expanding at a CAGR of 5.6% from 2016 to 2024. Browse the full Emu Oil Market - Market Growth, Future Prospects and Competitive Analysis, 2016 – 2024 report at  http://www.credenceresearch.com/report/emu-oil-market The market is witnessing growth due to rise in consumer awareness regardi
Read more

E-commerce Logistics Market: Global Industry Analysis and Opportunity Assessment, 2017-2025

According to a new market report published by Credence Research, Inc., “ E-commerce Logistics Market Size  (By Operational Area (International (Cross-border) and Domestic), By Service Type (Transportation, Warehousing, and Other Services), By Geography (North America, Europe, Asia Pacific, and Rest of the World)) – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025” the global e-commerce logistics market is expected to grow at a CAGR of 19.5% during the forecast period 2015 – 2025. Browse the full E-commerce Logistics Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2025 report at  http://www.credenceresearch.com/report/e-commerce-market Market Insights Logistics has become an integral component of an e-commerce business as it is responsible for planning, control and flow of products from the point of origin to end-consumers. The proliferation of the e-commerce sector and consequent rise in cross-border (international) e-
Read more

Acquired Hemophilia Treatment Market Opportunities, Trends, Size And Market Share 2017 - 2025 - Credence Research

​ The latest market report published by Credence Research, Inc. “Global  Acquired Hemophilia Treatment Market  - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2023,” the acquired hemophilia treatment market was valued at USD 1,923.4 Mn in 2015, and is expected to reach USD 2,474.7 Mn by 2023, expanding at a CAGR of 3.2% from 2016 to 2023. Market Insights According to National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners suggest that, acquired hemophilia can potentially cause life-threatening bleeding complications in severe cases and in around 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known i.e. idiopathic. Browse th
Read more